I really appreciate the effort made by some but I am in line with TonyWAIW, I would like to have a DCF model (like the one done on Neuren) done on the Acadia pipeline from 3/4 years ago (I say Acadia because we all know it ) when it had Nuplazid already approved and in the running on various very important pathologies, trofinetide in phase 3 and other preclinical studies in various partnerships (PW was not there) and with the stock quoted between $45 and $60, in this hypothetical study done let's say in 2020 how much could we expect after 4 years (so now)? Would it have been right for shareholders to accept a takeover at $70/80 in 2020? Since I am a simple shareholder of Neuren, I blindly trust the management otherwise I would have already sold, so whatever the hypothetical sales figure for Neuren is it will be well accepted, and $50 is over 4B USD not peanuts.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
I really appreciate the effort made by some but I am in line...
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B |
Open | High | Low | Value | Volume |
$20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1024 | $20.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.53 | 285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10 | 20.100 |
1 | 480 | 20.080 |
3 | 174 | 20.000 |
1 | 150 | 19.980 |
1 | 434 | 19.940 |
Price($) | Vol. | No. |
---|---|---|
20.570 | 295 | 1 |
20.600 | 4094 | 1 |
20.610 | 13 | 1 |
20.650 | 2488 | 1 |
20.700 | 252 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |